These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 2180549)

  • 1. Cholecystokinin-tetrapeptide induces panic attacks in patients with panic disorder.
    Bradwejn J; Koszycki D; Meterissian G
    Can J Psychiatry; 1990 Feb; 35(1):83-5. PubMed ID: 2180549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings.
    Bradwejn J; Koszycki D; Shriqui C
    Arch Gen Psychiatry; 1991 Jul; 48(7):603-10. PubMed ID: 2069490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased ACTH concentrations associated with cholecystokinin tetrapeptide-induced panic attacks in patients with panic disorder.
    Ströhle A; Holsboer F; Rupprecht R
    Neuropsychopharmacology; 2000 Mar; 22(3):251-6. PubMed ID: 10693152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of alprazolam on cholecystokinin-tetrapeptide-induced panic and hypothalamic-pituitary-adrenal-axis activity: a placebo-controlled study.
    Zwanzger P; Eser D; Aicher S; Schüle C; Baghai TC; Padberg F; Ella R; Möller HJ; Rupprecht R
    Neuropsychopharmacology; 2003 May; 28(5):979-84. PubMed ID: 12700707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of CI-988 on cholecystokinin tetrapeptide-induced panic symptoms in healthy volunteers.
    Bradwejn J; Koszycki D; Paradis M; Reece P; Hinton J; Sedman A
    Biol Psychiatry; 1995 Dec; 38(11):742-6. PubMed ID: 8580227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of state and trait anxiety on the panic response to CCK-4.
    Eser D; Wenninger S; Baghai T; Schüle C; Rupprecht R
    J Neural Transm (Vienna); 2008 Jun; 115(6):917-20. PubMed ID: 18414777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatic and psychological symptoms during isoproterenol-induced panic attacks.
    Balon R; Yeragani VK; Pohl R; Muench J; Berchou R
    Psychiatry Res; 1990 May; 32(2):103-12. PubMed ID: 2195575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anxiolyticlike effects of atrial natriuretic peptide on cholecystokinin tetrapeptide-induced panic attacks: preliminary findings.
    Wiedemann K; Jahn H; Yassouridis A; Kellner M
    Arch Gen Psychiatry; 2001 Apr; 58(4):371-7. PubMed ID: 11296098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Megestrol attenuates the hormonal response to CCK-4-induced panic attacks.
    Raedler TJ; Jahn H; Goedeken B; Gescher DM; Kellner M; Wiedemann K
    Depress Anxiety; 2006; 23(3):139-44. PubMed ID: 16470820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorder: a controlled study.
    Dunner DL; Ishiki D; Avery DH; Wilson LG; Hyde TS
    J Clin Psychiatry; 1986 Sep; 47(9):458-60. PubMed ID: 2875064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emotional and cognitive factors connected with response to cholecystokinin tetrapeptide in healthy volunteers.
    Aluoja A; Shlik J; Vasar V; Kingisepp PH; Jagomägi K; Vasar E; Bradwejn J
    Psychiatry Res; 1997 Jan; 66(1):59-67. PubMed ID: 9061804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dose-ranging study of the behavioral and cardiovascular effects of CCK-tetrapeptide in panic disorder.
    Bradwejn J; Koszycki D; Annable L; Couëtoux du Tertre A; Reines S; Karkanias C
    Biol Psychiatry; 1992 Nov; 32(10):903-12. PubMed ID: 1467375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct panicogenic activity of sodium lactate and cholecystokinin tetrapeptide in patients with panic disorder.
    Plag J; Gaudlitz K; Zschucke E; Yassouridis A; Pyrkosch L; Wittmann A; Holsboer F; Ströhle A
    Curr Pharm Des; 2012; 18(35):5619-26. PubMed ID: 22632477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responses to hypercarbia induced by acetazolamide in panic disorder patients.
    Mathew RJ; Wilson WH; Tant S
    Am J Psychiatry; 1989 Aug; 146(8):996-1000. PubMed ID: 2750998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anxiety sensitivity and response to cholecystokinin tetrapeptide in healthy volunteers.
    Koszycki D; Cox BJ; Bradwejn J
    Am J Psychiatry; 1993 Dec; 150(12):1881-3. PubMed ID: 8238648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of cholecystokinin-tetrapeptide and carbon dioxide in health volunteers.
    Koszycki D; Bradwejn J; Bourin M
    Eur Neuropsychopharmacol; 1991 May; 1(2):137-41. PubMed ID: 1821703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One milligram of lorazepam does not decrease anxiety induced by CCK-4 in healthy volunteers: investigation of neural correlates with BOLD MRI.
    Schunck T; Mathis A; Erb G; Namer IJ; Hode Y; Demazières A; Luthringer R
    J Psychopharmacol; 2011 Jan; 25(1):52-9. PubMed ID: 20498136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alprazolam, propranolol, and placebo in the treatment of panic disorder and agoraphobia with panic attacks.
    Munjack DJ; Crocker B; Cabe D; Brown R; Usigli R; Zulueta A; McManus M; McDowell D; Palmer R; Leonard M
    J Clin Psychopharmacol; 1989 Feb; 9(1):22-7. PubMed ID: 2651490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholecystokinin-4 and panic.
    Abelson JL; Nesse RM
    Arch Gen Psychiatry; 1990 Apr; 47(4):395. PubMed ID: 2322091
    [No Abstract]   [Full Text] [Related]  

  • 20. In healthy volunteers responses to challenge with cholecystokinin tetrapeptide differ between administration during REM and delta sleep.
    Kronenberg G; Schredl M; Fiedler K; Heuser I
    Depress Anxiety; 2001; 14(2):141-4. PubMed ID: 11668667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.